MatthewFWszolekMD

PubMed

• A contemporary comparison of laparoscopic versus open partial nephrectomy for renal cell carcinoma.
  Nicaise, E., Edouard Nicaise, Adam S Feldman, Andrew Gusev, Alice Yu, Naren Nimmagadda, Matthew F Wszolek, Francis McGovern, Michael L Blute, Douglas M Dahl> ;BMC Urology. 2024 Mar 12
• Pyelonephritis is an Underrecognized Cause of CKD in Patients With Orthotopic Ileal Neobladder Substitution.
  Ouyang, T., Strohbehn, I., Katz-Agranov, N., Gupta, S., Wang, Q., Seethapathy, R., Hanna, P., Madken, M., Seethapathy, H., Heller, H., Wszolek, M., Steele, D., Klepeis...> ;Kidney International Reports. 2023 Dec 1
• 4 citations
  Sequential intravesical gemcitabine/docetaxel provides a durable remission in recurrent high-risk NMIBC following BCG therapy.
  Kendrick Yim, Kevin Melnick, Sarah L Mott, Filipe L F Carvalho, Affan Zafar, Timothy N Clinton, Matthew Mossanen, Graeme S Steele, Michelle Hirsch, Natalie Rizzo, Chin...> ;Urologic Oncology. 2023 Nov 1
• 34 citations
  Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis.
  Alexandre R Zlotta, Leslie K Ballas, Andrzej Niemierko, Katherine Lajkosz, Cynthia Kuk, Gus Miranda, Michael Drumm, Andrea Mari, Ethan Thio, Neil E Fleshner, Girish S ...> ;The Lancet. Oncology. 2023 Jun 1
• Mortality related to the use of stapler devices and clip appliers: Analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience database.
  Balaji N Reddy, Madanika Subhash, Mark Vangel, Stephen Markowiak, Dipak Delvadia, Shirin Razdan, Sanjay Razdan, Matthew Wszolek> ;Surgery. 2023 May 1
• 3 citations
  Mucinous adenocarcinoma of the prostatic urethra after brachytherapy for prostatic adenocarcinoma: a case series.
  Ting Zhao, Hao-Wen Chuang, Kristine M Cornejo, Rory K Crotty, Douglas M Dahl, Matthew F Wszolek, Dimitar V Zlatev, Anthony L Zietman, Chin-Lee Wu> ;Human Pathology. 2022 Oct 1
• 3 citations
  Healthcare Resource Utilization After Surgical Treatment of Cancer: Value of Minimally Invasive Surgery.
  Rocco Ricciardi, Robert Neil Goldstone, Todd Francone, Matthew Wszolek, Hugh Auchincloss, Alexander de Groot, I-Fan Shih, Yanli Li> ;Surgical Endoscopy. 2022 Oct 1
• 7 citations
  Combination MRI-targeted and systematic prostate biopsy may overestimate gleason grade on final surgical pathology and impact risk stratification.
  Alice Yu, Tammer Yamany, Amirkasra Mojtahed, Nawar Hanna, Edouard Nicaise, Mukesh G. Harisinghani, Chin-Lee Wu, Douglas M. Dahl, Matthew F. Wszolek, Michael L. Blute, ...> ;Urologic Oncology. 2021 Sep 17
• 9 citations
  Complications and Outcomes of Salvage Cystectomy after Trimodality Therapy.
  Alberto C. Pieretti, Ross Krasnow, Michael Drumm, Andrew Gusev, Douglas M. Dahl, Francis J. McGovern, Michael L. Blute, William U. Shipley, Jason A. Efstathiou, Adam S...> ;The Journal of Urology. 2021 Feb 22
• 3 citations
  TCF21 promotes luminal-like differentiation and suppresses metastasis in bladder cancer
  , , , , , , , , , , , , , , , > ;Molecular Cancer Research. 2020 Jun 1
• 19 citations
  Multiparametric Magnetic Resonance Imaging-Ultrasound Fusion Biopsy Improves but Does Not Replace Standard Template Biopsy for the Detection of Prostate Cancer.
  Nawar Hanna, Matthew F. Wszolek, Amirkasra Mojtahed, Edouard Nicaise, Bo Wu, Francisco Gelpi-Hammerschmidt, Keyan Salari, Douglas M. Dahl, Michael L. Blute, Mukesh G. ...> ;The Journal of Urology. 2019 Oct 9
• Does knowing the risk of relapse in localized renal cell carcinoma matter
  Matthew F. Wszolek> ;BJU International. 2019 Feb 1
• 38 citations
  PARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53.
  Qi Liu, Liliana Gheorghiu, Michael Drumm, R.H. Clayman, Alec Eidelman, Matthew F. Wszolek, Aria F. Olumi, Adam S. Feldman, Meng Wang, Lynnette Marcar, Deborah Citrin, ...> ;Oncogene. 2018 Mar 7
• 26 citations
  Incidence, Clinicopathological Risk Factors, Management and Outcomes of Nonmuscle Invasive Recurrence after Complete Response to Trimodality Therapy for Muscle Invasiv...
  Alejandro Sanchez, Matthew F. Wszolek, Andrzej Niemierko, R.H. Clayman, Michael Drumm, Dayron Rodriguez, Adam S. Feldman, Douglas M. Dahl, Niall M. Heney, William U. S...> ;The Journal of Urology. 2018 Feb 1
• 43 citations
  Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing Therapy
  Ross Krasnow, Michael Drumm, H.J. Roberts, Andrzej Niemierko, Chin-Lee Wu, Shulin Wu, Jing Zhang, Niall M. Heney, Matthew F. Wszolek, Michael L. Blute, Adam S. Feldman...> ;European Urology. 2017 Jul 1
• 215 citations
  Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hos...
  Nicholas J. Giacalone, William U. Shipley, R.H. Clayman, Andrzej Niemierko, Michael Drumm, Niall M. Heney, M.D. Michaelson, Richard T. Lee, Philip J. Saylor, Matthew F...> ;European Urology. 2017 Jun 1
• 14 citations
  Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasis
  Beat Roth, Isuru Jayaratna, Debasish Sundi, Jonathan Melquist, Woonyoung Choi, Sima P. Porten, Giovanni Nitti, Neema Navai, Matthew F. Wszolek, Charles C. Guo, Bogdan ...> ;Oncotarget. 2017 May 23
• 23 citations
  Robotic-assisted laparoscopic versus open salvage radical prostatectomy following radiotherapy.
  Patrick A. Kenney, Cayce Nawaf, Mahmoud Mustafa, Sijin Wen, Matthew F. Wszolek, Curtis A. Pettaway, John F. Ward, John W. Davis, Louis L. Pisters> ;The Canadian Journal of Urology. 2016 Jun 1
• 10 citations
  Bladder cancer: Quality of life in patients with non-muscle-invasive bladder cancer.
  Alejandro Sanchez, Matthew F. Wszolek> ;Nature Reviews. Urology. 2015 Apr 1
• 1 citations
  Laparoscopy for the detection and treatment of early complications from minimally invasive urologic surgery.
  Matthew F. Wszolek, David Canes, Alireza Moinzadeh, Andrea Sorcini> ;Journal of Endourology. 2014 Oct 2
• 69 citations
  Plasma microRNA profiles for bladder cancer detection.
  Liana Adam, Matthew F. Wszolek, Chang Gong Liu, Wang Jing, Lixia Diao, Alexander Zien, Jitao D. Zhang, David A. Jackson, Colin P.N. Dinney> ;Urologic Oncology. 2013 Nov 1
• 141 citations
  Refining Patient Selection for Neoadjuvant Chemotherapy before Radical Cystectomy
  Stephen H. Culp, Rian J. Dickstein, H. Barton Grossman, Shanna Pretzsch, Sima P. Porten, Siamak Daneshmand, Jie Cai, Susan Groshen, Arlene O. Siefker-Radtke, Randall E...> ;The Journal of Urology. 2014 Jan 1
• 84 citations
  Phase I Trial of Intravesical Recombinant Adenovirus Mediated Interferon-α2b Formulated in Syn3 for Bacillus Calmette-Guérin Failures in Nonmuscle Invasive Bladder Cancer
  Colin P.N. Dinney, Mark B. Fisher, Neema Navai, Michael A. O’Donnell, David L. Cutler, Alice Abraham, Sophia Young, Beth Hutchins, Maria Caceres, Narendra S Kishnani, ...> ;The Journal of Urology. 2013 Sep 1
• 100 citations
  The p63 Protein Isoform ΔNp63α Inhibits Epithelial-Mesenchymal Transition in Human Bladder Cancer Cells ROLE OF MIR-205
  Mai Tran, Woonyoung Choi, Matthew F. Wszolek, Neema Navai, I-Ling C. Lee, Giovanni Nitti, Sijin Wen, Elsa R. Flores, Arlene O. Siefker-Radtke, Bogdan Czerniak, Colin P...> ;The Journal of Biological Chemistry. 2013 Feb 1
• 102 citations
  A MicroRNA expression profile defining the invasive bladder tumor phenotype
  Matthew F. Wszolek, Kimberly M. Rieger-Christ, Patrick A. Kenney, Justin J. Gould, Brasil Silva Neto, Amanda K. LaVoie, Tanya Logvinenko, John A. Libertino, Ian C. Sum...> ;Urologic Oncology. 2011 Nov 1
• Join now to see all